The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
And the pharmacologic agent in that case turns out to be very low dose or as some of you may have heard of it referred to as microdosing of psilocybin. Now, I do want to say because it would be entirely inappropriate for me to not say this, that in most areas of the world and particularly in the United States, psilocybin is still illegal.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
However, I will provide a link to the study that shows that microdosing of psilocybin for a series of weeks on a daily basis. So these are dosages of psilocybin that do not induce hallucination and do not massively shift mood or internal states in any way that has people feeling like they are acting or feeling that much different although some people do report a subjective shift. Does seem to increase divergent thinking ability.
what they found was an enhancement of creative. That is, divergent and convergent thinking not surprising given the fact that the 5-HT2A receptor activity is increased by microdosing of psilocybin and 5-HT2A receptors are present both on the neural circuits that underlie divergent and convergent thinking.
A single dose of psilocybin enhanced creative thinking, empathy, and subjective well-being in participants for up to seven days after use.